PreprintReviewVersion 1Preserved in Portico This version is not peer-reviewed
Impact of an Oncology Clinical Pharmacist on Patient Engagement in Self-Administered Oral Oncolytic Therapy: Case Study of Venetoclax in Acute Myeloid Leukemia Patients
Palmer, S.; Chen, A.; Dennison, T.; Czech, C.; Auten, J.; Buhlinger, K.; Muluneh, B. Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics. Pharmacy2021, 9, 130.
Palmer, S.; Chen, A.; Dennison, T.; Czech, C.; Auten, J.; Buhlinger, K.; Muluneh, B. Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics. Pharmacy 2021, 9, 130.
Palmer, S.; Chen, A.; Dennison, T.; Czech, C.; Auten, J.; Buhlinger, K.; Muluneh, B. Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics. Pharmacy2021, 9, 130.
Palmer, S.; Chen, A.; Dennison, T.; Czech, C.; Auten, J.; Buhlinger, K.; Muluneh, B. Impact of Oncology Pharmacists on the Knowledge, Attitude, and Practices of Clinicians to Enhance Patient Engagement of Self-Administered Oral Oncolytics. Pharmacy 2021, 9, 130.
Abstract
Oncology clinical pharmacists are uniquely positioned to make interventions to increase patient activation and engagement. To accomplish this goal, pharmacists can target health system-related, provider-related, and patient-related factors to help enhance patient-centered care and drive behavioral health changes. Interventions that pharmacists must tackle include educating team members and patients on the medication acquisition process, communicating urgency of treatment, optimizing workflows, facilitating guideline recommendations, preventing, and managing treatment toxicities, and promoting patient self-advocacy through education and shared decision-making. As crucial members of the healthcare team, oncology clinical pharmacists can simplify highly complex treatment regimens to facilitate and optimize patients’ ownership of their care. This review will focus on the example of venetoclax treatment in acute myeloid leukemia to demonstrate the impact that pharmacists provide that leads to behavioral change of patients and clinicians.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
